US Trends

how much does ozempic cost in australia

Ozempic in Australia typically costs about $130–$200 per month when purchased privately, which works out to roughly $1,560–$2,400 per year for most users paying full price. How much you personally pay depends on whether you are using it for type 2 diabetes on the PBS, or off‑label for weight loss.

Quick Scoop

  • For type 2 diabetes on the PBS
    • Ozempic is listed on the Pharmaceutical Benefits Scheme (PBS) for diabetes, so eligible patients pay a capped “co‑payment” per prescription.
* As of **1 January 2026** , the **maximum out‑of‑pocket cost for any PBS prescription** has dropped to **$25** for non‑concession patients; concession card holders pay less again.
* That means if you have a valid PBS script for diabetes and can get stock, you pay up to about **$25 per pen** , not $150+.
  • For weight loss (off‑label) / non‑PBS use
    • Ozempic is not PBS‑subsidised for weight loss, so people using it for obesity or general weight management usually pay private prices of around $130–$200 per month.
* Pens are usually dosed once weekly, so one pen often covers roughly a month at common maintenance doses, giving an annual cost close to **$2,000** for many users.
* Some patients report paying even more through telehealth subscription services that bundle medication plus coaching or support.
  • Why people say “it’s nearly $2,000 a year”
    • A major Australian medical body has pointed out that at current private prices, annual Ozempic spend for off‑label weight loss can “approach $2,000”, and has argued that obesity treatment should be PBS‑subsidised to reduce this financial burden.
* Clinics and bariatric specialists commonly quote **$130–$200 per month** as the going range for Ozempic used in obesity medicine, matching this estimate.
  • Forum and real‑world chatter
    • On Australian forums and Reddit, people using Ozempic talk about a wide spread of real‑world prices:
      • Some PBS‑eligible users say they pay around the PBS co‑payment (previously about $30, now lower), when they can actually find stock.
  * Others using telehealth weight‑loss programs report much higher “all‑in” monthly fees because they’re paying for medical reviews, coaching and guaranteed supply on top of the drug cost.
  * A few mention importing or sourcing via overseas pharmacies to reduce cost or secure supply, but this comes with quality, legal and safety risks.
  • Context for 2025–2026 in Australia
    • Demand for GLP‑1 drugs like Ozempic and Wegovy has surged for weight loss, which has contributed to supply issues and pushed more users towards private, non‑PBS channels.
* Policy discussions in 2025 and 2026 have focused on whether these drugs should be subsidised for obesity given their effects on cardiovascular risk and other obesity‑related conditions, but currently Ozempic’s PBS listing remains limited to type 2 diabetes.

Bottom line: if you are on PBS for diabetes , think around $25 or less per script in 2026 ; if you are using Ozempic privately for weight loss , think roughly $130–$200 a month out of pocket.

Information gathered from public forums or data available on the internet and portrayed here.